US Stock MarketDetailed Quotes
LRMR Larimar Therapeutics
- 6.330
- -0.310-4.67%
Close Nov 29 13:00 ET
- 6.310
- -0.020-0.32%
Post 17:01 ET
403.90MMarket Cap-5504P/E (TTM)
6.685High6.260Low505.90KVolume6.660Open6.640Pre Close3.22MTurnover1.60%Turnover RatioLossP/E (Static)63.81MShares13.68052wk High2.04P/B200.14MFloat Cap3.34052wk Low--Dividend TTM31.62MShs Float664.320Historical High--Div YieldTTM6.40%Amplitude1.530Historical Low6.360Avg Price1Lot Size
About Larimar Therapeutics Company
Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.
Company Profile
SymbolLRMR
Company NameLarimar Therapeutics
Listing DateJun 19, 2014
Issue Price16.00
Founded2005
CEODr. Carole Ben-Maimon, M.D.
MarketNASDAQ
Employees42
Fiscal Year Ends12-31
Address3 Bala Plaza East,Suite 506
CityBala Cynwyd
ProvincePennsylvania
CountryUnited States of America
Zip Code19004
Phone1-844-511-9056
Websitehttp://larimartx.com
Company Executives
- Name
- Position
- Salary
- Dr. Carole Ben-Maimon, M.D.
- Director, President and Chief Executive Officer
- 3.14M
- Dr. Gopi Shankar, F.A.A.P.,M.B.A.,PhD
- Chief Development Officer
- 1.38M
- Dr. Russell G. Clayton, D.O.
- Chief Medical Officer
- --
- Michael Celano
- Chief Financial Officer and Principal Accounting Officer
- 1.42M
- Joseph Truitt
- Chairman of the Board
- 114.96K
- Dr. Jeffrey W. Sherman, F.A.C.P.,M.D.
- Independent Director
- 56.43K
- Frank E. Thomas
- Independent Director
- 86.21K
- Thomas Edward Hamilton
- Independent Director
- 77.77K
- Jonathan S. Leff
- Independent Director
- 79.96K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data